References
- World Health Organization. WHO Director- General´s-opening-remarks at the media briefing on COVID-19, 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020(2020).
- Coronaviridae study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544. doi:https://doi.org/10.1038/s41564-020-0695-z.
- Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:https://doi.org/10.1016/j.ijantimicag.2020.105924.
- Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:https://doi.org/10.1016/S0140-6736(20)30183-5.
- Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel corona virüs through conjunctiva. Med Rxiv. 2020.
- Laboratory testing of 2019 novel coronavirus (2019-nCoV)in suspected human cases: interim guidance, 17 January 2020.
- Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019‐nCoV) by real‐time RT‐PCR. Euro Surveill. 2020;25(3):2000045. doi:https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel corona virüs pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507‐513. doi:https://doi.org/10.1016/S0140-6736(20)30211-7.
- Lin C, Ye R, Xia YL. A meta‐analysis to evaluate the effectiveness of real‐time PCR for diagnosing novel coronavirus infections. Genet Mol Res. 2015;14(4):15634‐15641. doi:https://doi.org/10.4238/2015.December.1.15.
- Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with corona virüs disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:https://doi.org/10.1001/jamaophthalmol.2020.1291.
- Sun X, Zhang X, Chen X, et al. The infection evidence of SARS-CoV-2 in ocular surface: a single-center cross sectional study. MedRxiv. 2020.
- Xia J, Tong J, Liu M, Shen Y. Guo D Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection. J Med Virol. 2020;92:589–594. doi:https://doi.org/10.1002/jmv.25725.
- Kumar K, Prakash AA, Gangasagara SB, et al. Presence of Viral RNA of SARS-CoV-2 in Conjunctival Swab Specimens of COVID-19 Patients. Indian J Ophthalmol. 2020;68(6):1015–1017. doi:https://doi.org/10.4103/ijo.IJO_1287_20.
- Sindhuja K, Lomi N, Asif MI, Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study. Indian J Ophthalmol. 2020;68(8):1546–1550. doi:https://doi.org/10.4103/ijo.IJO_1319_20.
- Yang Y, Yang M, Shen C, et al. Laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. MedRxiv.2020.
- Ellington S, Strid P, Tong VT. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):769–775. doi:https://doi.org/10.15585/mmwr.mm6925a1.